Personalised treatment innovations in the field of rheumatology are transforming patient care and outcomes, driven by significant advances in understanding the origins of rheumatological diseases. Professor Xenofon Baraliakos, president-elect of EULAR, speaks to Helen Quinn about the biggest challenges and opportunities in the field and where he sees rheumatology advancing to next.
Helena Beer is an editor for Hospital Healthcare Europe, specializing in healthcare news and updates. With a focus on medical advancements, treatment approvals, and healthcare practices, Helena provides insightful and informative articles on a wide range of topics in the healthcare industry.